首页> 外文OA文献 >Development of Silk Fibroin/Chitosan Based Porous Scaffolds for Cartilage Tissue Engineering
【2h】

Development of Silk Fibroin/Chitosan Based Porous Scaffolds for Cartilage Tissue Engineering

机译:基于丝素蛋白/壳聚糖的软骨组织工程多孔支架的开发

摘要

The present research deals with the development of silk fibroin (SF) and chitosan (CS) based microporous 3D scaffolds for cartilage tissue engineering applications. Porous scaffolds prepared from SF/CS blends with varying ratio of SF and CS by freeze drying method were characterized for physicochemical, mechanical and biological properties. Among the various blend ratios, SF/CS with 80:20 blend was found to be the most favourable for achieving certain superior scaffold properties than other SF/CS blends. The scaffold possesses open pore microstructure with interconnected pore network with desired pore size (71-210 μm), average pore size (186±32.2 μm), porosity (82.2±1.3%) and compressive strength (190 ±0.2kPa). Bioactive molecules namely glucosamine sulphate (Glu) and chondroitin sulphate (Chs),the structural components of native cartilage tissue were added individually and in combination with the aim of improving cell supportive and glycosaminoglycan (GAG) secretive properties thereby facilitating cartilage specific ECM production. Thus, SF/CS/Glu and SF/CS/Chs scaffolds with varying percentage of Chs and Glu concentrations were developed. The SF/CS/Glu scaffold with 1% (w/v) Glu was the most favourable composition have pore size of 40-190 μm, average pore size of 104±19.6 μm, 79.6+4.12% porosity and 202 ±12 kPa compressive strength. A marginal improvement in scaffold property was also achieved specifically by the addition of 0.8 % (w/v) Chs. The scaffold possess a pore size of 44-196 μm, average pore size 105±19.5% porosity of 87+2.13% and 204 ±13 kPa compressive strength. In-vitro cell culture study using human mesenchymal stem cell (hMSCs) derived from umbilical cord blood (UCB) has shown an enhanced cell attachment, proliferation and differentiation (GAG assay) with SF/CS/Chs scaffolds than its counterpart SF/CS and SF/CS/Glu scaffolds. An enhanced scaffold porosity, hydrophilicity, cell adhesion and cell proliferation were further achieved by the incorporation both Glu and Chs in combination into SF/CS blend. Moreover, the increased GAG secretion shown by SF/CS/Glu/Chs scaffolds represents the superiority of the scaffold than the other scaffold towards cartilage tissue regeneration. Thus, it has been demonstrated that the scaffold comprising of SF/CS/Glu/Chs is the potential 3D polymer matrix which can be used as a suitable platform for cartilage tissue regeneration.
机译:本研究涉及用于软骨组织工程应用的基于丝素蛋白(SF)和壳聚糖(CS)的微孔3D支架的开发。通过冻干法由具有不同比例的SF和CS的SF / CS共混物制备的多孔支架的理化,机械和生物学特性进行了表征。在各种混合比中,与其他SF / CS混合相比,具有80:20混合比的SF / CS最有利于获得某些优异的脚手架性能。该支架具有具有相互连通的孔网络的开孔微结构,具有所需的孔径(71-210μm),平均孔径(186±32.2μm),孔隙率(82.2±1.3%)和抗压强度(190±0.2kPa)。分别添加生物活性分子,即硫酸氨基葡萄糖(Glu)和硫酸软骨素(Chs),以及天然软骨组织的结构成分,旨在改善细胞支持和糖胺聚糖(GAG)分泌特性,从而促进软骨特异性ECM的产生。因此,开发了具有变化的Chs和Glu浓度百分比的SF / CS / Glu和SF / CS / Chs支架。具有1%(w / v)Glu的SF / CS / Glu支架是最有利的组合物,其孔径为40-190μm,平均孔径为104±19.6μm,孔隙率为79.6 + 4.12%,压缩强度为202±12 kPa强度。通过添加0.8%(w / v)的Chs,也可以实现支架性能的轻微改善。支架的孔尺寸为44-196μm,平均孔尺寸为105±19.5%,孔隙率为87±2.13%,抗压强度为204±13kPa。使用源自脐带血(UCB)的人间充质干细胞(hMSCs)进行的体外细胞培养研究显示,与SF / CS / Chs支架相比,SF / CS / Chs支架增强了细胞附着,增殖和分化(GAG分析) SF / CS / Glu支架。通过将Glu和Chs组合加入SF / CS混合物中,可以进一步提高支架的孔隙率,亲水性,细胞粘附性和细胞增殖能力。此外,SF / CS / Glu / Chs支架显示的GAG分泌增加代表该支架比其他支架在软骨组织再生方面的优越性。因此,已经证明包含SF / CS / Glu / Chs的支架是潜在的3D聚合物基质,其可以用作软骨组织再生的合适平台。

著录项

  • 作者

    Vishwanath Varshini;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号